Restenosis is a clinical problem after coronary angioplasty associated
with major ischemic events or repeat interventions in 20-50 % of the
patients undergoing this procedure. Major efforts have been undertaken
in the past decade to successfully prevent or treat restenosis but no
pharmacologic approach to the problem has as yet been identified to b
e effective enough in clinical conditions. New strategies to cope with
restenosis are targeted by local application of ionizing radiation wh
ich markedly reduces cell proliferation after angioplasty in animal ex
periments. Preliminary clinical trials indicate that endovascular radi
ation therapy is a safe and effective means to treat restenosis. Rando
mized, multicenter studies with long follow-up periods are needed to s
upport these early results.